|
|
Tuesday, June 29, 2004
Halozyme Therapeutics Expands Scientific Advisory Board
San Diego-based Halozyme Therapeutics has appointed Gerhard Baumgartner, MD to its Scientific Advisory Board. Professor Baumgartner is at the Ludwig Boltzmann Institute for Clinical Oncology in Vienna, Austria, and focuses on using bovine hyaluronidase enzymes to enhance the effectiveness of chemotherapy agents.
posted on Tuesday, June 29, 2004
|
RSS
Email
Previous news:
Tuesday, October 7, 2008
Monday, October 6, 2008
Friday, October 3, 2008
Thursday, October 2, 2008
Wednesday, October 1, 2008
|